Form 4: Zivo Bioscience Director Maggiore Increases Stake with Recent Stock and Warrant Purchase

Director Christopher D. Maggiore increases his holdings in Zivo Bioscience through the purchase of common stock and common stock purchase warrants.

Summary

• On July 26, 2024, Christopher D. Maggiore, a director and 10% owner of Zivo Bioscience, Inc., purchased 2,080 shares of common stock at a price of $8.05 per share.
• The same day, Maggiore also acquired 208 common stock purchase warrants with an exercise price of $8.05, expiring on July 26, 2029.
• Following these transactions, Maggiore directly owns 467,107 shares of Zivo Bioscience common stock and 208 common stock purchase warrants.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a director increasing their stake usually signals confidence. However, the transaction size is relatively small.

Positives

• A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. An increase in holdings by a director is generally viewed favorably.

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive sign.

Key Dates

Keywords

Zivo Bioscience, Director, Christopher D. Maggiore, Stock Purchase, Warrant Purchase, Beneficial Ownership, Form 4